Terms: = Ovarian cancer AND DDX10, HRH-J8, 1662, ENSG00000178105, Q13206 AND Treatment
4 results:
1. Analysis of risk factors for recurrence in infertile endometrial cancer patients after
Wei H; Pan N; Wang Y; Ma C
Front Endocrinol (Lausanne); 2023; 14():1224622. PubMed ID: 38075071
[TBL] [Abstract] [Full Text] [Related]
2. Bone Metastases of Endometrial Carcinoma Treated by Surgery: A Report on 13 Patients and a Review of the Medical Literature.
Wang J; Dai Y; Ji T; Guo W; Wang Z; Wang J
Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682407
[TBL] [Abstract] [Full Text] [Related]
3. Epigenetic down-regulated ddx10 promotes cell proliferation through Akt/NF-κB pathway in ovarian cancer.
Gai M; Bo Q; Qi L
Biochem Biophys Res Commun; 2016 Jan; 469(4):1000-5. PubMed ID: 26713367
[TBL] [Abstract] [Full Text] [Related]
4. Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.
Minig L; Franchi D; Boveri S; Casadio C; Bocciolone L; Sideri M
Ann Oncol; 2011 Mar; 22(3):643-649. PubMed ID: 20876910
[TBL] [Abstract] [Full Text] [Related]
